nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS1—malignant glioma	0.556	0.636	CbGaD
Oxaprozin—PTGS2—malignant glioma	0.318	0.364	CbGaD
Oxaprozin—Lung infection—Temozolomide—malignant glioma	0.00868	0.106	CcSEcCtD
Oxaprozin—Meningitis—Carmustine—malignant glioma	0.0038	0.0465	CcSEcCtD
Oxaprozin—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00151	0.0184	CcSEcCtD
Oxaprozin—Hearing impaired—Temozolomide—malignant glioma	0.0015	0.0183	CcSEcCtD
Oxaprozin—Coma—Carmustine—malignant glioma	0.00135	0.0165	CcSEcCtD
Oxaprozin—Aplastic anaemia—Temozolomide—malignant glioma	0.00134	0.0163	CcSEcCtD
Oxaprozin—Sepsis—Carmustine—malignant glioma	0.00128	0.0156	CcSEcCtD
Oxaprozin—Deafness—Temozolomide—malignant glioma	0.00116	0.0141	CcSEcCtD
Oxaprozin—Vascular purpura—Temozolomide—malignant glioma	0.00116	0.0141	CcSEcCtD
Oxaprozin—Hepatic failure—Temozolomide—malignant glioma	0.00115	0.0141	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0011	0.0134	CcSEcCtD
Oxaprozin—Purpura—Temozolomide—malignant glioma	0.00107	0.0131	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00107	0.0131	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000931	0.0114	CcSEcCtD
Oxaprozin—Benzphetamine—POR—malignant glioma	0.000928	0.119	CrCbGaD
Oxaprozin—Pancytopenia—Carmustine—malignant glioma	0.000879	0.0107	CcSEcCtD
Oxaprozin—Sweating increased—Temozolomide—malignant glioma	0.000871	0.0106	CcSEcCtD
Oxaprozin—Pancytopenia—Temozolomide—malignant glioma	0.000849	0.0104	CcSEcCtD
Oxaprozin—Dysuria—Temozolomide—malignant glioma	0.000836	0.0102	CcSEcCtD
Oxaprozin—Hyperglycaemia—Carmustine—malignant glioma	0.000835	0.0102	CcSEcCtD
Oxaprozin—Pneumonia—Carmustine—malignant glioma	0.00083	0.0101	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000816	0.00997	CcSEcCtD
Oxaprozin—Renal failure—Carmustine—malignant glioma	0.000811	0.00991	CcSEcCtD
Oxaprozin—Hyperglycaemia—Temozolomide—malignant glioma	0.000806	0.00985	CcSEcCtD
Oxaprozin—Stomatitis—Carmustine—malignant glioma	0.000804	0.00982	CcSEcCtD
Oxaprozin—Pneumonia—Temozolomide—malignant glioma	0.000802	0.0098	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00079	0.00966	CcSEcCtD
Oxaprozin—Stomatitis—Temozolomide—malignant glioma	0.000777	0.00949	CcSEcCtD
Oxaprozin—Sinusitis—Temozolomide—malignant glioma	0.000748	0.00914	CcSEcCtD
Oxaprozin—Haemoglobin—Carmustine—malignant glioma	0.000744	0.00909	CcSEcCtD
Oxaprozin—Haemorrhage—Carmustine—malignant glioma	0.000741	0.00905	CcSEcCtD
Oxaprozin—Hallucination—Carmustine—malignant glioma	0.000737	0.009	CcSEcCtD
Oxaprozin—Haemoglobin—Temozolomide—malignant glioma	0.000719	0.00879	CcSEcCtD
Oxaprozin—Hepatitis—Temozolomide—malignant glioma	0.000716	0.00874	CcSEcCtD
Oxaprozin—Haemorrhage—Temozolomide—malignant glioma	0.000716	0.00874	CcSEcCtD
Oxaprozin—Hallucination—Temozolomide—malignant glioma	0.000712	0.0087	CcSEcCtD
Oxaprozin—Erythema multiforme—Temozolomide—malignant glioma	0.000677	0.00827	CcSEcCtD
Oxaprozin—Tinnitus—Temozolomide—malignant glioma	0.000667	0.00815	CcSEcCtD
Oxaprozin—Arrhythmia—Carmustine—malignant glioma	0.000662	0.00808	CcSEcCtD
Oxaprozin—Alopecia—Carmustine—malignant glioma	0.000654	0.00799	CcSEcCtD
Oxaprozin—Alopecia—Temozolomide—malignant glioma	0.000632	0.00773	CcSEcCtD
Oxaprozin—Warfarin—CYP2C18—malignant glioma	0.000629	0.0806	CrCbGaD
Oxaprozin—Dysgeusia—Temozolomide—malignant glioma	0.00061	0.00745	CcSEcCtD
Oxaprozin—Vision blurred—Carmustine—malignant glioma	0.000608	0.00742	CcSEcCtD
Oxaprozin—Tremor—Carmustine—malignant glioma	0.000604	0.00738	CcSEcCtD
Oxaprozin—Anaemia—Carmustine—malignant glioma	0.000596	0.00728	CcSEcCtD
Oxaprozin—Vision blurred—Temozolomide—malignant glioma	0.000587	0.00717	CcSEcCtD
Oxaprozin—Tremor—Temozolomide—malignant glioma	0.000584	0.00713	CcSEcCtD
Oxaprozin—Bifonazole—CYP2B6—malignant glioma	0.000582	0.0746	CrCbGaD
Oxaprozin—Ill-defined disorder—Temozolomide—malignant glioma	0.000578	0.00706	CcSEcCtD
Oxaprozin—Leukopenia—Carmustine—malignant glioma	0.000577	0.00705	CcSEcCtD
Oxaprozin—Anaemia—Temozolomide—malignant glioma	0.000576	0.00703	CcSEcCtD
Oxaprozin—Angioedema—Temozolomide—malignant glioma	0.000569	0.00695	CcSEcCtD
Oxaprozin—Malaise—Temozolomide—malignant glioma	0.000562	0.00686	CcSEcCtD
Oxaprozin—Vertigo—Temozolomide—malignant glioma	0.00056	0.00684	CcSEcCtD
Oxaprozin—Fenbufen—PTGS1—malignant glioma	0.00056	0.0717	CrCbGaD
Oxaprozin—Convulsion—Carmustine—malignant glioma	0.000559	0.00682	CcSEcCtD
Oxaprozin—Leukopenia—Temozolomide—malignant glioma	0.000558	0.00681	CcSEcCtD
Oxaprozin—Hypertension—Carmustine—malignant glioma	0.000557	0.0068	CcSEcCtD
Oxaprozin—Palpitations—Temozolomide—malignant glioma	0.000551	0.00673	CcSEcCtD
Oxaprozin—Anxiety—Carmustine—malignant glioma	0.000547	0.00668	CcSEcCtD
Oxaprozin—Convulsion—Temozolomide—malignant glioma	0.00054	0.00659	CcSEcCtD
Oxaprozin—Hypertension—Temozolomide—malignant glioma	0.000538	0.00657	CcSEcCtD
Oxaprozin—Confusional state—Carmustine—malignant glioma	0.00053	0.00648	CcSEcCtD
Oxaprozin—Anxiety—Temozolomide—malignant glioma	0.000529	0.00646	CcSEcCtD
Oxaprozin—Oedema—Carmustine—malignant glioma	0.000526	0.00643	CcSEcCtD
Oxaprozin—Discomfort—Temozolomide—malignant glioma	0.000524	0.0064	CcSEcCtD
Oxaprozin—Infection—Carmustine—malignant glioma	0.000523	0.00639	CcSEcCtD
Oxaprozin—Dry mouth—Temozolomide—malignant glioma	0.000519	0.00634	CcSEcCtD
Oxaprozin—Thrombocytopenia—Carmustine—malignant glioma	0.000515	0.00629	CcSEcCtD
Oxaprozin—Tachycardia—Carmustine—malignant glioma	0.000513	0.00627	CcSEcCtD
Oxaprozin—Confusional state—Temozolomide—malignant glioma	0.000513	0.00626	CcSEcCtD
Oxaprozin—Anaphylactic shock—Temozolomide—malignant glioma	0.000508	0.00621	CcSEcCtD
Oxaprozin—Oedema—Temozolomide—malignant glioma	0.000508	0.00621	CcSEcCtD
Oxaprozin—Infection—Temozolomide—malignant glioma	0.000505	0.00617	CcSEcCtD
Oxaprozin—Anorexia—Carmustine—malignant glioma	0.000501	0.00613	CcSEcCtD
Oxaprozin—Thrombocytopenia—Temozolomide—malignant glioma	0.000498	0.00608	CcSEcCtD
Oxaprozin—Hypotension—Carmustine—malignant glioma	0.000492	0.00601	CcSEcCtD
Oxaprozin—Hyperhidrosis—Temozolomide—malignant glioma	0.000491	0.006	CcSEcCtD
Oxaprozin—Anorexia—Temozolomide—malignant glioma	0.000485	0.00592	CcSEcCtD
Oxaprozin—Insomnia—Carmustine—malignant glioma	0.000476	0.00581	CcSEcCtD
Oxaprozin—Paraesthesia—Carmustine—malignant glioma	0.000472	0.00577	CcSEcCtD
Oxaprozin—Dyspnoea—Carmustine—malignant glioma	0.000469	0.00573	CcSEcCtD
Oxaprozin—Somnolence—Carmustine—malignant glioma	0.000468	0.00571	CcSEcCtD
Oxaprozin—Insomnia—Temozolomide—malignant glioma	0.00046	0.00562	CcSEcCtD
Oxaprozin—Decreased appetite—Carmustine—malignant glioma	0.000457	0.00559	CcSEcCtD
Oxaprozin—Phenytoin—CYP2C18—malignant glioma	0.000457	0.0586	CrCbGaD
Oxaprozin—Paraesthesia—Temozolomide—malignant glioma	0.000457	0.00558	CcSEcCtD
Oxaprozin—Dyspnoea—Temozolomide—malignant glioma	0.000453	0.00554	CcSEcCtD
Oxaprozin—Somnolence—Temozolomide—malignant glioma	0.000452	0.00552	CcSEcCtD
Oxaprozin—Constipation—Carmustine—malignant glioma	0.00045	0.0055	CcSEcCtD
Oxaprozin—Dyspepsia—Temozolomide—malignant glioma	0.000448	0.00547	CcSEcCtD
Oxaprozin—Decreased appetite—Temozolomide—malignant glioma	0.000442	0.0054	CcSEcCtD
Oxaprozin—Constipation—Temozolomide—malignant glioma	0.000435	0.00531	CcSEcCtD
Oxaprozin—Feeling abnormal—Carmustine—malignant glioma	0.000434	0.0053	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Carmustine—malignant glioma	0.00043	0.00526	CcSEcCtD
Oxaprozin—Feeling abnormal—Temozolomide—malignant glioma	0.000419	0.00512	CcSEcCtD
Oxaprozin—Body temperature increased—Carmustine—malignant glioma	0.000416	0.00508	CcSEcCtD
Oxaprozin—Abdominal pain—Carmustine—malignant glioma	0.000416	0.00508	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000416	0.00508	CcSEcCtD
Oxaprozin—Urticaria—Temozolomide—malignant glioma	0.000404	0.00493	CcSEcCtD
Oxaprozin—Body temperature increased—Temozolomide—malignant glioma	0.000402	0.00491	CcSEcCtD
Oxaprozin—Abdominal pain—Temozolomide—malignant glioma	0.000402	0.00491	CcSEcCtD
Oxaprozin—Modafinil—CYP2B6—malignant glioma	0.000383	0.049	CrCbGaD
Oxaprozin—Asthenia—Carmustine—malignant glioma	0.000377	0.00461	CcSEcCtD
Oxaprozin—Asthenia—Temozolomide—malignant glioma	0.000365	0.00446	CcSEcCtD
Oxaprozin—Diarrhoea—Carmustine—malignant glioma	0.00036	0.0044	CcSEcCtD
Oxaprozin—Pruritus—Temozolomide—malignant glioma	0.00036	0.00439	CcSEcCtD
Oxaprozin—Diphenhydramine—CYP2C18—malignant glioma	0.000358	0.0459	CrCbGaD
Oxaprozin—Carbamazepine—CYP2B6—malignant glioma	0.000349	0.0447	CrCbGaD
Oxaprozin—Dizziness—Carmustine—malignant glioma	0.000348	0.00425	CcSEcCtD
Oxaprozin—Diarrhoea—Temozolomide—malignant glioma	0.000348	0.00425	CcSEcCtD
Oxaprozin—Methadone—CYP2C18—malignant glioma	0.000346	0.0443	CrCbGaD
Oxaprozin—Phenytoin—CYP2B6—malignant glioma	0.000339	0.0435	CrCbGaD
Oxaprozin—Dizziness—Temozolomide—malignant glioma	0.000336	0.00411	CcSEcCtD
Oxaprozin—Vomiting—Carmustine—malignant glioma	0.000334	0.00409	CcSEcCtD
Oxaprozin—Rash—Carmustine—malignant glioma	0.000332	0.00405	CcSEcCtD
Oxaprozin—Benzphetamine—CYP2B6—malignant glioma	0.000332	0.0425	CrCbGaD
Oxaprozin—Dermatitis—Carmustine—malignant glioma	0.000331	0.00405	CcSEcCtD
Oxaprozin—Headache—Carmustine—malignant glioma	0.00033	0.00403	CcSEcCtD
Oxaprozin—Modafinil—SLC6A3—malignant glioma	0.000326	0.0418	CrCbGaD
Oxaprozin—Vomiting—Temozolomide—malignant glioma	0.000323	0.00395	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS1—malignant glioma	0.000321	0.0412	CrCbGaD
Oxaprozin—Rash—Temozolomide—malignant glioma	0.000321	0.00392	CcSEcCtD
Oxaprozin—Dermatitis—Temozolomide—malignant glioma	0.00032	0.00391	CcSEcCtD
Oxaprozin—Fenbufen—PTGS2—malignant glioma	0.00032	0.041	CrCbGaD
Oxaprozin—Headache—Temozolomide—malignant glioma	0.000318	0.00389	CcSEcCtD
Oxaprozin—Nausea—Carmustine—malignant glioma	0.000312	0.00382	CcSEcCtD
Oxaprozin—Nausea—Temozolomide—malignant glioma	0.000302	0.00369	CcSEcCtD
Oxaprozin—Benzphetamine—SLC6A3—malignant glioma	0.000283	0.0362	CrCbGaD
Oxaprozin—Diphenhydramine—CYP2B6—malignant glioma	0.000266	0.034	CrCbGaD
Oxaprozin—Flurbiprofen—PTGS1—malignant glioma	0.000262	0.0336	CrCbGaD
Oxaprozin—Methadone—CYP2B6—malignant glioma	0.000257	0.0329	CrCbGaD
Oxaprozin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000242	0.00652	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000237	0.0064	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000235	0.00634	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000235	0.00633	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000233	0.00628	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00022	0.00594	CbGpPWpGaD
Oxaprozin—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000218	0.00587	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000212	0.00571	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000206	0.00555	CbGpPWpGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000205	0.00554	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000204	0.00549	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000204	0.00549	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	0.000202	0.00545	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000194	0.00524	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	0.000192	0.00517	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	0.000187	0.00503	CbGpPWpGaD
Oxaprozin—Phenylbutazone—PTGS2—malignant glioma	0.000184	0.0235	CrCbGaD
Oxaprozin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	0.000183	0.00493	CbGpPWpGaD
Oxaprozin—Diphenhydramine—PTGS1—malignant glioma	0.000175	0.0224	CrCbGaD
Oxaprozin—PTGS1—Biological oxidations—GSTT1—malignant glioma	0.000166	0.00449	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000162	0.00437	CbGpPWpGaD
Oxaprozin—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00016	0.00433	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.00016	0.00432	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000154	0.00416	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.000152	0.00411	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.00015	0.00405	CbGpPWpGaD
Oxaprozin—Flurbiprofen—PTGS2—malignant glioma	0.00015	0.0192	CrCbGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.000149	0.00403	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000147	0.00397	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000146	0.00394	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000141	0.0038	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	0.000141	0.00379	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00014	0.00377	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	0.000133	0.00359	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	0.000131	0.00354	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000125	0.00336	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000124	0.00336	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	0.000124	0.00333	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000123	0.00332	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	0.000118	0.00319	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	0.000118	0.00319	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—RTEL1—malignant glioma	0.000117	0.00315	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—GSTP1—malignant glioma	0.000115	0.00311	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000114	0.00307	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	0.000112	0.00301	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000108	0.00292	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000107	0.00289	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000107	0.00288	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	0.000107	0.00287	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000102	0.00275	CbGpPWpGaD
Oxaprozin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	0.000101	0.00272	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	9.87e-05	0.00266	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	9.65e-05	0.0026	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	9.5e-05	0.00256	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—RTEL1—malignant glioma	9.26e-05	0.0025	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	9.19e-05	0.00248	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	9.12e-05	0.00246	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	9e-05	0.00243	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	8.86e-05	0.00239	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	8.85e-05	0.00239	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTT1—malignant glioma	8.74e-05	0.00236	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	8.6e-05	0.00232	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	8.45e-05	0.00228	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	8.44e-05	0.00228	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.33e-05	0.00225	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	8.23e-05	0.00222	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—PTGS1—malignant glioma	8.19e-05	0.00221	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	8.16e-05	0.0022	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.06e-05	0.00218	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	7.54e-05	0.00203	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	7.41e-05	0.002	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	6.89e-05	0.00186	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—COX8A—malignant glioma	6.7e-05	0.00181	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	6.69e-05	0.0018	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	6.62e-05	0.00179	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.61e-05	0.00178	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.4e-05	0.00173	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	6.22e-05	0.00168	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—RTEL1—malignant glioma	6.13e-05	0.00165	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	6.1e-05	0.00165	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTP1—malignant glioma	6.06e-05	0.00164	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	5.98e-05	0.00161	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	5.96e-05	0.00161	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	5.95e-05	0.00161	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL2—malignant glioma	5.94e-05	0.0016	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	5.93e-05	0.0016	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	5.74e-05	0.00155	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ASMT—malignant glioma	5.69e-05	0.00154	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	5.68e-05	0.00153	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	5.63e-05	0.00152	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	5.62e-05	0.00152	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.56e-05	0.0015	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	5.47e-05	0.00148	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BCAN—malignant glioma	5.35e-05	0.00144	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—COX8A—malignant glioma	5.32e-05	0.00143	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BCAN—malignant glioma	5.07e-05	0.00137	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	4.83e-05	0.0013	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.75e-05	0.00128	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MYC—malignant glioma	4.65e-05	0.00125	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	4.59e-05	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—DTX1—malignant glioma	4.59e-05	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	4.54e-05	0.00123	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.52e-05	0.00122	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ASMT—malignant glioma	4.52e-05	0.00122	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.51e-05	0.00122	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.46e-05	0.0012	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.42e-05	0.00119	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.38e-05	0.00118	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TNF—malignant glioma	4.33e-05	0.00117	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—IDH2—malignant glioma	4.31e-05	0.00116	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BCAN—malignant glioma	4.25e-05	0.00115	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.24e-05	0.00114	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.07e-05	0.0011	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2B6—malignant glioma	4.06e-05	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.05e-05	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TP53—malignant glioma	3.82e-05	0.00103	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.8e-05	0.00103	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—IDH1—malignant glioma	3.71e-05	0.001	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HEY2—malignant glioma	3.6e-05	0.000972	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SPHK1—malignant glioma	3.59e-05	0.000969	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—COX8A—malignant glioma	3.52e-05	0.00095	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP2C18—malignant glioma	3.52e-05	0.000949	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IDH1—malignant glioma	3.52e-05	0.000949	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.43e-05	0.000927	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—IDH2—malignant glioma	3.43e-05	0.000924	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HEY1—malignant glioma	3.33e-05	0.0009	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.32e-05	0.000895	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HIST1H3B—malignant glioma	3.24e-05	0.000874	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.23e-05	0.000871	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2B6—malignant glioma	3.22e-05	0.000869	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.16e-05	0.000853	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.15e-05	0.000849	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.09e-05	0.000834	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.02e-05	0.000815	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ASMT—malignant glioma	2.99e-05	0.000808	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JAG2—malignant glioma	2.96e-05	0.000798	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—IDH1—malignant glioma	2.95e-05	0.000795	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.94e-05	0.000794	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.93e-05	0.000789	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.92e-05	0.000788	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.92e-05	0.000787	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SPHK1—malignant glioma	2.85e-05	0.000769	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTT1—malignant glioma	2.84e-05	0.000768	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BCAN—malignant glioma	2.81e-05	0.000759	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP2C18—malignant glioma	2.79e-05	0.000753	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.68e-05	0.000724	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.66e-05	0.000717	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.63e-05	0.00071	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.6e-05	0.0007	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—H3F3A—malignant glioma	2.5e-05	0.000675	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BCHE—malignant glioma	2.48e-05	0.000669	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC5A5—malignant glioma	2.45e-05	0.00066	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.4e-05	0.000647	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—JAG1—malignant glioma	2.36e-05	0.000636	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.31e-05	0.000625	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.31e-05	0.000625	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FBXW7—malignant glioma	2.31e-05	0.000624	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.29e-05	0.000619	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—IDH2—malignant glioma	2.27e-05	0.000612	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTT1—malignant glioma	2.26e-05	0.000609	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.19e-05	0.000591	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.14e-05	0.000577	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.13e-05	0.000575	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTGS1—malignant glioma	2.12e-05	0.000571	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.11e-05	0.000569	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2e-05	0.00054	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTP1—malignant glioma	1.97e-05	0.000532	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BCHE—malignant glioma	1.97e-05	0.000531	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—IDH1—malignant glioma	1.95e-05	0.000526	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC5A5—malignant glioma	1.94e-05	0.000524	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CAT—malignant glioma	1.92e-05	0.000518	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SPHK1—malignant glioma	1.89e-05	0.000509	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.85e-05	0.000499	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.84e-05	0.000496	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOR1—malignant glioma	1.81e-05	0.000489	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CDKN2B—malignant glioma	1.81e-05	0.000489	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.74e-05	0.00047	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HES1—malignant glioma	1.73e-05	0.000466	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NCOR1—malignant glioma	1.72e-05	0.000463	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFRA—malignant glioma	1.64e-05	0.000444	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.59e-05	0.000429	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.59e-05	0.000428	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTP1—malignant glioma	1.57e-05	0.000422	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.53e-05	0.000414	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CAT—malignant glioma	1.52e-05	0.000411	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TERT—malignant glioma	1.51e-05	0.000408	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HLA-A—malignant glioma	1.51e-05	0.000408	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTT1—malignant glioma	1.5e-05	0.000403	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFB—malignant glioma	1.48e-05	0.000399	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CAV1—malignant glioma	1.48e-05	0.000399	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGFR1—malignant glioma	1.47e-05	0.000397	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HIF1A—malignant glioma	1.45e-05	0.000391	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOR1—malignant glioma	1.44e-05	0.000388	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.41e-05	0.000381	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS1—malignant glioma	1.4e-05	0.000378	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CAV1—malignant glioma	1.4e-05	0.000378	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.4e-05	0.000377	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—malignant glioma	1.35e-05	0.000363	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BAD—malignant glioma	1.32e-05	0.000355	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOTCH1—malignant glioma	1.3e-05	0.000352	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BCHE—malignant glioma	1.3e-05	0.000352	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARG—malignant glioma	1.3e-05	0.00035	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.29e-05	0.000347	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CD80—malignant glioma	1.28e-05	0.000345	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APC—malignant glioma	1.28e-05	0.000344	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGF—malignant glioma	1.26e-05	0.00034	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTPN11—malignant glioma	1.25e-05	0.000338	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.22e-05	0.000328	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.21e-05	0.000325	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BRAF—malignant glioma	1.2e-05	0.000323	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CD—malignant glioma	1.18e-05	0.000319	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CAV1—malignant glioma	1.17e-05	0.000316	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT2—malignant glioma	1.17e-05	0.000315	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CD—malignant glioma	1.12e-05	0.000303	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.12e-05	0.000302	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF2—malignant glioma	1.07e-05	0.00029	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—malignant glioma	1.07e-05	0.000288	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.05e-05	0.000284	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTP1—malignant glioma	1.04e-05	0.00028	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CB—malignant glioma	1.03e-05	0.000278	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARG—malignant glioma	1.03e-05	0.000278	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—malignant glioma	1.02e-05	0.000276	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CAT—malignant glioma	1.01e-05	0.000272	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MDM2—malignant glioma	1e-05	0.000271	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RAF1—malignant glioma	1e-05	0.00027	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—ERBB2—malignant glioma	9.9e-06	0.000267	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CB—malignant glioma	9.77e-06	0.000264	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOR1—malignant glioma	9.53e-06	0.000257	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CD—malignant glioma	9.39e-06	0.000253	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTEN—malignant glioma	8.91e-06	0.00024	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PTEN—malignant glioma	8.44e-06	0.000228	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CB—malignant glioma	8.18e-06	0.000221	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CAV1—malignant glioma	7.77e-06	0.00021	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—malignant glioma	7.55e-06	0.000204	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.42e-06	0.0002	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.07e-06	0.000191	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PTEN—malignant glioma	7.07e-06	0.000191	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MYC—malignant glioma	7.02e-06	0.000189	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—EGFR—malignant glioma	6.86e-06	0.000185	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARG—malignant glioma	6.83e-06	0.000184	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—KRAS—malignant glioma	6.48e-06	0.000175	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CA—malignant glioma	6.28e-06	0.00017	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.22e-06	0.000168	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PIK3CA—malignant glioma	5.96e-06	0.000161	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.42e-06	0.000146	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—malignant glioma	5.37e-06	0.000145	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—malignant glioma	5.13e-06	0.000139	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CA—malignant glioma	4.99e-06	0.000135	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT1—malignant glioma	4.87e-06	0.000131	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTEN—malignant glioma	4.68e-06	0.000126	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—malignant glioma	4.08e-06	0.00011	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.3e-06	8.91e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—malignant glioma	2.7e-06	7.28e-05	CbGpPWpGaD
